Leukogene Announces Two Presentations at the AACR Annual Meeting
13 Apr 2026 //
PHARMIWEB
Leukogene Secures SCRA Funding for Cancer Immunotherapy
12 Nov 2025 //
BUSINESSWIRE
FDA Designates Leukogene`s M2T-CD33 For Acute Myeloid Leukemia
05 Nov 2025 //
BUSINESSWIRE

Market Place
Sourcing Support